The pharmacological, pharmacodynamic and clinical properties of a new vasoactive agent: A meeting on Dalfon 500 mg. Held during the IVth European-American Symposium on Venous Diseases. Washington, D.C., March 31-April 2, 1987.
D000818:Animals; D004145:Diosmin / Q000494:pharmacology / Q000627:therapeutic use; D005419:Flavonoids / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D014652:Vascular Diseases / Q000188:drug therapy*
D005419:Flavonoids; D004145:Diosmin